Benzinga | Oct 11, 2021 01:30PM EDT

Medtronic's Hugo Surgical Robot Wins Regulatory Nod In Europe

* Medtronic plc (NYSE:MDT) has secured European approval for its Hugo surgical robot.

* Hugo performed its first human procedure in June this year, a minimally invasive prostatectomy in Chile.

* It has since expanded to Latin America, with a series of initial gynecological surgeries completed in Panama.

* The robotic platform, made up of modular surgical arms on wheeled carts, has also checked off its first operation in the Asia-Pacific region through a prostatectomy in India.

* The Company's systems are linked to a global patient registry, which tracks outcomes and feeds that data back into the platform.

* The CE mark covers urologic and gynecologic procedures, such as hysterectomies and the removal of uterine fibroids.

* The Hugo system is designed to provide a lower barrier to entry for hospitals looking to expand their reach in robotic surgery.

* Related: Medtronic Expands Recall of MiniMed 600 Series Insulin Pumps.

* Price Action: MDT shares are down 0.40% at $124.77 during the market session on the last check Monday.